Single-dose liposomal amphotericin B (AmBisome®) for the treatment of visceral leishmaniasis in East Africa: study protocol for a randomized controlled trial (Q34704669)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Single-dose liposomal amphotericin B (AmBisome®) for the treatment of visceral leishmaniasis in East Africa: study protocol for a randomized controlled trial |
scientific article |
Statements
1 reference
Single-dose liposomal amphotericin B (AmBisome®) for the treatment of visceral leishmaniasis in East Africa: study protocol for a randomized controlled trial (English)
1 reference
Asrat Hailu
1 reference
Tansy Edwards
1 reference
Raymond Omollo
1 reference
Eltahir A G Khalil
1 reference
Sisay Yifru
1 reference
Brima Musa
1 reference
Ahmed Musa
1 reference
Monique Wasunna
1 reference
Catherine Royce
1 reference
Sally Ellis
1 reference
Manica Balasegaram
1 reference
1 reference
Identifiers
1 reference